Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry Hatem SolimanBhupendra RawalStefan Ambs Original article 24 January 2013 Pages: 829 - 837
Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen Martin J. CannonHannah E. GoyneMaurizio Chiriva-Internati Original article 25 January 2013 Pages: 839 - 849
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes Alessia ParodiFlorinda BattagliaGilberto Filaci Original article 29 January 2013 Pages: 851 - 862
Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity Victoria L. GreenAnna MichnoJohn Greenman Original article 29 January 2013 Pages: 863 - 873
Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6 Philippe UlsemerGemma HendersonSteffen Goletz Original article 05 February 2013 Pages: 875 - 887
A novel melittin-MhIL-2 fusion protein inhibits the growth of human ovarian cancer SKOV3 cells in vitro and in vivo tumor growth Mingjun LiuJinbao ZongGuirong Sun Original article 27 February 2013 Pages: 889 - 895
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response Chiara CamisaschiPaola FilipazziChiara Castelli Original Article Open access 16 April 2013 Pages: 897 - 908
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer Cristina IclozanScott AntoniaDmitry Gabrilovich Original Article 16 April 2013 Pages: 909 - 918
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine Masanori NoguchiTetsuro SasadaKyogo Itoh Focussed Research Review 30 November 2012 Pages: 919 - 929
Circulating tumor cells as therapy-related biomarkers in cancer patients Tobias M. GorgesKlaus Pantel Focussed Research Review 12 January 2013 Pages: 931 - 939
FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs Ann L. WhiteH. T. Claude ChanMartin J. Glennie Focussed Research Review 31 March 2013 Pages: 941 - 948
CD40 immunotherapy for pancreatic cancer Robert H. VonderheideDavid L. BajorGregory L. Beatty Focussed Research Review 16 April 2013 Pages: 949 - 954
An introduction to mass cytometry: fundamentals and applications Scott D. TannerVladimir I. BaranovThaddeus C. George Focussed Research Review 07 April 2013 Pages: 955 - 965
Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges Pramod K. SrivastavaFei Duan Focussed Research Review Open access 19 April 2013 Pages: 967 - 974
Toward next-generation cancer immunotherapy: 10th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23–25, 2012 Björn-Philipp KlokeSarah KutscherSine Reker Hadrup Meeting Report 09 January 2013 Pages: 975 - 981
